Somu Subramaniam - Jun 6, 2023 Form 4 Insider Report for Ventyx Biosciences, Inc. (VTYX)

Signature
/s/ Christopher Krueger, as Attorney-in-Fact
Stock symbol
VTYX
Transactions as of
Jun 6, 2023
Transactions value $
-$1,423,590
Form type
4
Date filed
6/8/2023, 09:50 PM
Previous filing
Apr 25, 2023
Next filing
Jun 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTYX Common Stock Sale -$144K -4.13K -0.04% $35.00 9.87M Jun 6, 2023 See Footnotes F1, F2, F3, F4, F5, F6
transaction VTYX Common Stock Sale -$916K -25.8K -0.26% $35.48 9.85M Jun 7, 2023 See Footnotes F4, F5, F6, F7, F9, F10
transaction VTYX Common Stock Sale -$364K -10.1K -0.1% $36.10 9.84M Jun 7, 2023 See Footnotes F4, F5, F6, F8, F9, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average share price of an aggregate total of 4,128 shares sold in the price range of $35.00 to $35.02. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2 Consists of: (i) 5,286,971 shares held by NSV Investments I, LP, (ii) 1,037,831 shares held by NSV Investments III, LP, (iii) 374,756 shares held by NSV Master Limited Partnership II, LP, (iv) 352,151 shares held by NSV 2019 Opportunities Fund, LP, (v) 304,170 shares held by NSV 2018 New Horizons Fund, LP, (vi) 330,816 shares held by Life & Tech, (vii) 434,423 shares held by New Science Ventures, LLC, (viii) 967,609 shares held by NSV Partners III, LP, (ix) 279,748 shares held by NSV Investments II, LP, (x) 296,359 shares held by NSV Partners II, LLC, (xi) 53,918 shares held by NSV Growth Opportunities Fund, LP, (xii) 45,191 shares held by New Science Ventures Fund III, LP, (xiii) 39,719 shares held by NSV 2017 Opportunities Fund, LP, (xiv) 27,696 shares held by NSV 2018 Opportunities Fund, LP, (xv) 21,421 shares held by NSV 2016 Opportunities Fund, LP,
F3 (Continued from Footnote 2) (xvi) 14,247 shares held by New Science Ventures Fund III (Offshore), LP, and (xvii) 5,891 shares held by NSV 2016 Opportunities Fund (Offshore), LP (collectively, the "NSV Funds"). The NSV Funds disclaim beneficial ownership over the shares owned by them, except to the extent of their pecuniary interest therein.
F4 NSV Partners III, LP is the general partner of NSV 2018 New Horizons Fund LP, NSV Investments I, LP, NSV 2018 Opportunities Fund, LP, NSV 2019 Opportunities Fund, LP, NSV Growth Opportunities Fund, LP, NSV Investments III, LP, and NSV Investments II, LP.
F5 NSV Partners II, LLC is the general partner of New Science Ventures Fund III, LP, New Science Ventures Fund III (Offshore), LP, NSV 2016 Opportunities Fund, LP, NSV 2016 Opportunities Fund (Offshore), LP, NSV 2017 Opportunities Fund, LP, and NSV Master Limited Partnership II, LP.
F6 The Reporting Person is the majority member and managing member of NSV Partners III GP, LLC, and may be deemed to have voting and dispositive power over the shares owned by each entity of which NSV Partners III, LP is general partner. The Reporting Person is the majority member and managing member NSV Partners II, LLC, and may be deemed to have voting and dispositive power over the shares owned by each entity of which NSV Partners II, LLC is general partner. The Reporting Person is the majority member and managing member of NSV Management, LLC, and may be deemed to share voting and dispositive power over the shares held by Life & Tech, for which NSV Management, LLC is the investment advisor. The Reporting Person disclaims beneficial ownership over the shares owned by each of the NSV Funds, except to the extent of his pecuniary interest therein.
F7 Represents the weighted average share price of an aggregate total of 25,801 shares sold in the price range of $35.00 to $35.99. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F8 Represents the weighted average share price of an aggregate total of 10,071 shares sold in the price range of $36.00 to $36.125. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F9 Consists of: (i) 5,286,971 shares held by NSV Investments I, LP, (ii) 1,037,831 shares held by NSV Investments III, LP, (iii) 374,756 shares held by NSV Master Limited Partnership II, LP, (iv) 347,792 shares held by NSV 2019 Opportunities Fund, LP, (v) 296,821 shares held by NSV 2018 New Horizons Fund, LP, (vi) 330,816 shares held by Life & Tech, (vii) 434,423 shares held by New Science Ventures, LLC, (viii) 967,609 shares held by NSV Partners III, LP, (ix) 279,748 shares held by NSV Investments II, LP, (x) 296,359 shares held by NSV Partners II, LLC, (xi) 53,466 shares held by NSV Growth Opportunities Fund, LP, (xii) 38,240 shares held by New Science Ventures Fund III, LP, (xiii) 33,610 shares held by NSV 2017 Opportunities Fund, LP, (xiv) 23,436 shares held by NSV 2018 Opportunities Fund, LP,
F10 (Continued from Footnote 9) (xv) 18,126 shares held by NSV 2016 Opportunities Fund, LP, (xvi) 12,056 shares held by New Science Ventures Fund III (Offshore), LP, and (xvii) 4,985 shares held by NSV 2016 Opportunities Fund (Offshore), LP. The NSV Funds disclaim beneficial ownership over the shares owned by them, except to the extent of their pecuniary interest therein.